🇺🇸 FDA
Patent

US 7259236

RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7259236 (RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof) held by The Regents of the University of California expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61K39/00